Poland Neurology Clinical Trials Market Analysis

Poland Neurology Clinical Trials Market Analysis

$ 3999

The Poland Neurology Clinical Trials market is projected to grow from $30.3 Mn in 2022 to $48.2 Mn by 2030, registering a CAGR of 5.95% during the forecast period of 2022 - 2030. The market will be driven by a skilled workforce, a supportive regulatory framework, and a relatively low cost of conducting research. The market is segmented by phase, by study design & by indication. Some of the major players include Biogen Inc., Pfizer Inc. & Novartis AG.

ID: IN10PLCT005 CATEGORY: Clinical Trials GEOGRAPHY: Poland AUTHOR: Vidhi Upadhyay

Buy Now

Poland Neurology Clinical Trials Market Executive Summary

The Poland Neurology Clinical Trials market is projected to grow from $30.3 Mn in 2022 to $48.2 Mn by 2030, registering a CAGR of 5.95% during the forecast period of 2022 - 2030. Poland is situated in Central Europe, with a population of 37.9 million people, and is the European Union's fifth-most populated member state. Poland is one of the major clinical trial markets in CEE, accounting for over 20% of all clinical studies conducted. According to the most recent WHO statistics, Alzheimer's and Dementia fatalities in Poland reached 3,701 in 2020, accounting for 1.04% of all deaths. In Poland, around 90,000 strokes occur each year, with 85% of them being ischemic.

Clinical trials are an essential element in healthcare research since they are used to evaluate the quality and safety of new drugs, medical equipment, or treatments. Clinical trials are conducted to determine that innovative therapies or drugs are safe, effective, and appropriate for use in patient care. Neurology clinical trials, in particular, focus on treatments for neurological ailments such as Alzheimer's disease, multiple sclerosis, Parkinson's disease, stroke, and others. Poland is a developing nation in clinical trials and has been actively participating in neurology clinical trials. Throughout the last decade, the number of clinical trials undertaken in Poland has steadily increased. While there are obstacles to the expansion of neurology clinical trials in Poland, the nation has a trained workforce, a supportive regulatory environment, and a relatively cheap cost of doing research, all of which are big factors for the field's continued expansion.

Poland Neurology Clinical Trials Market

Market Dynamics

Market Growth Drivers

The trained workforce in Poland is one of the key drivers of neurology clinical trials. Poland offers a huge pool of highly skilled medical experts, such as neurologists and clinical researchers, who can perform clinical trials professionally and efficiently. Poland has a well-developed clinical trial regulatory system that is in line with the EU Clinical Trials Regulation and corresponds to worldwide clinical research standards. Moreover, Poland has cheaper expenses by 30% on average than the US, owing to efficiency in patient recruiting and lower wages and fees and has launched various measures to stimulate cooperation between business and academics, which has aided in the expansion of clinical trial operations in the area of neurology.

Market Restraints

The small patient population is one of the major impediments to the expansion of neurology clinical trials in Poland. Poland has a smaller population than many other nations, which might restrict the number of people who are eligible for clinical studies. More financing for a clinical study is required in Poland since many hospitals and research organisations have low financial resources. This may lead to a scarcity of competent employees and insufficient infrastructure, limiting the expansion of clinical trials. Other nations in the area that are investing in clinical research, such as the Czech Republic and Hungary, compete with Poland.

Competitive Landscape

Key Players

  • Biogen Inc.
  • Pfizer Inc.
  • Novartis AG
  • Sanofi S.A.
  • Merck & Co.
  • AbbVie
  • Roche Holding AG
  • AstraZeneca plc
  • Eli Lilly and Company
  • GlaxoSmithKline

Healthcare Policies and Regulatory Landscape

Clinical trials might be funded privately or publicly. The product producer frequently funds commercial clinical studies (pharmaceutical company). The Medical Research Agency, formed in 2019, is the governmental entity in charge of supporting non-commercial clinical studies, such as those done by scientific organisations, universities, and so on. Before a medicine or device study may begin in Poland, the Regulatory Agency/Competent Authority (RA) and the Ethics Committee (EC) must both approve it.

1. Report Description of the Poland Neurology Clinical Trials Market
1.1 Research Scope and Assumption
1.2 Objective of the study
1.3 Research Methodology
1.4 Reason to buy the report

2. Poland Neurology Clinical Trials Market Executive Summary
2.1 Poland Neurology Clinical Trials Market –Industry Snapshot & key buying criteria, 2022-2030
2.2 Market Size, Growth Prospects, and Key findings

3. Market Dynamics of Poland Neurology Clinical Trials Market
3.1 Market Growth Drivers Analysis
3.2 Market Restrains Analysis

4. Poland Neurology Clinical Trials Market Segmentation

4.1 By Phase
4.1.1 Phase I
4.1.2 Phase II
4.1.3 Phase III
4.1.4 Phase IV

4.2 By Study Design Outlook
4.2.1 Epilepsy
4.2.2 Parkinson's Disease (PD)
4.2.3 Huntington's Disease 
4.2.4 Stroke
4.2.5 Traumatic Brain Injury (TBI)
4.2.6 Amyotrophic Lateral Sclerosis (ALS)
4.2.7 Muscle regeneration
4.2.4 Others

4.3 By Indication Outlook  
4.3.1 Interventional
4.3.2 Observational
4.3.3 Expanded Access

5. Poland Neurology Clinical Trials Market Share
5.1 Market Analysis, Insights, and Forecast – By Revenue

6. Competitive Landscape
6.1 Major Top Market Players

7. Key Company Profiles

7.1 Company 1
7.1.1 Overview
7.1.2 Financial Performance
7.1.3 Product & Services
7.1.4 Strategic initiatives

7.2 Company 2
7.2.1 Overview
7.2.2 Financial Performance
7.2.3 Product & Services
7.2.4 Strategic initiatives

7.3 Company 3
7.3.1 Overview
7.3.2 Financial Performance
7.3.3 Product & Services
7.3.4 Strategic initiatives

7.4 Company 4
7.4.1 Overview
7.4.2 Financial Performance
7.4.3 Product & Services
7.4.4 Strategic initiatives

7.5 Company 5
7.5.1 Overview
7.5.2 Financial Performance
7.5.3 Product & Services
7.5.4 Strategic initiatives  

8. Healthcare Policies and Regulatory Landscape
8.1 Healthcare Policies in Poland
8.2 Regulatory Framework in Poland
8.3 Pricing & Reimbursement Scenario in Poland Neurology Clinical Trials Market

9. Factors Driving Future Growth
9.1 New Trends and Development Poland Neurology Clinical Trials Market
9.2 Future Opportunities

10. Strategic Recommendations

Neurology Clinical Trials Market Segmentation

By Phase (Revenue, USD Billion):

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

By Study Design Outlook (Revenue, USD Billion):

  • Epilepsy
  • Parkinson's Disease (PD)
  • Huntington's Disease
  • Stroke
  • Traumatic Brain Injury (TBI)
  • Amyotrophic Lateral Sclerosis (ALS)
  • Muscle regeneration
  • Others

By Indication Outlook (Revenue, USD Billion):

  • Interventional
  • Observational
  • Expanded Access

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.


Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:



Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.



Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.

We value your inquiry and offer free customization with every report to fulfil your exact research needs.

This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 17 March 2023

Related reports (by category)

Related reports (by geography)

subscribe to our newsletter